Long‐term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation

Charatcharoenwitthaya, Phunchai; Pimentel, Sylvania; Talwalkar, Jayant A.; Enders, Felicity T.; Lindor, Keith D.; Krom, Ruud A.F.; Wiesner, Russell H.

doi:10.1002/lt.21124

Cited by 179Liver Diseases and ImmunityOrgan Transplantation Techniques and OutcomesPediatric Hepatobiliary Diseases and Treatments

Long‐term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation

Open access

Charatcharoenwitthaya, Phunchai, Pimentel, Sylvania, Talwalkar, Jayant A., Enders, Felicity T., Lindor, Keith D., Krom, Ruud A.F., Wiesner, Russell H.·2007·Liver Transplantation

DOI 10.1002/lt.21124

Open this paper in CoChat — free account Open PDF

Abstract

The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long-term follow-up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known. The aims of this study were as follows: 1) to determine the significance of recurrent PBC on overall survival among PBC patients who underwent LT, and 2) to determine the efficacy of UDCA treatment after LT in patients with recurrent PBC. A retrospective cohort study was conducted of 154 PBC patients who underwent LT with at least 1 yr of follow-up after transplantation from 1985 through 2005. A total of 52 patients with recurrent PBC were identified. After adjusting for age and gender, recurrent PBC was not associated with death or liver retransplantation (hazard ratio, 0.97, 95% confidence interval, 0.41-2.31; P = 0.9). A total of 38 patients with recurrent PBC received UDCA at an average dose of 12 mg/kg/day for a mean duration of 55 months. Over a 36-month period, an estimated 52% of UDCA-treated patients experienced normalization of serum alkaline phosphatase and alanine aminotransferase compared to 22% of untreated patients. There was no significant difference in the rate of histological progression between subgroups. UDCA did not influence patient and graft survival. In conclusion, the development of recurrent PBC has little impact on long-term survival or need for retransplantation. While UDCA therapy is associated with biochemical improvement, its role in delaying histologic progression remains unknown. In this short period of treatment, UDCA was not associated with improved patient and graft survival compared to untreated patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/lt.21124

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W. K., Therneau, T. M., Kosberg, C. L., D’Amico, G., Dickson, R. E., & Kim, W. R. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,989 · see citing works
Self-citation
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816 · see citing works
Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic Acid
Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.029 · Cited by 756 · see citing works
A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Balkau, B., Eschwège, E., Poupon, R., & the UDCA–PBC Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242204 · Cited by 755 · see citing works
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753 · see citing works
Primary biliary cirrhosis
Carey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735 · see citing works
Self-citation
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648 · see citing works
Self-citation
Liver Transplantation
Starzl, T. E., Demetris, A. J., & Thiel, D. H. V. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910123211505 · Cited by 575 · see citing works
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90021-3 · Cited by 487 · see citing works
Self-citation
Management of primary biliary cirrhosis
Heathcote, J. (2000) · Hepatology · doi:10.1053/he.2000.5984 · Cited by 412 · see citing works
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
Corpechot, C., Carrat, F., Bahr, A., Chrétien, Y., Poupon, R., & Poupon, R. Y. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.009 · Cited by 391 · see citing works
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
Corpechot, C., Carrat, F., Bonnand, A.-M., Poupon, R. E., & Poupon, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20240 · Cited by 316 · see citing works
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
COMBES, B., Carithers, R. L., Maddrey, W. C., Lin, D., McDonald, M. F., Wheeler, D. E., Eigenbrodt, E. H., Muñoz, S. J., Rubin, R., Garcia-Tsao, G., et al. (1995) · Hepatology · doi:10.1016/0270-9139(95)90294-5 · Cited by 302 · see citing works
Primary biliary cirrhosis
Talwalkar, J. A., & Lindor, K. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13808-1 · Cited by 299 · see citing works
Self-citation
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial
Parés, A. R., Caballería, L., Rodés, J., Bruguera, M., Rodrigo, L., García-Plaza, A., Berenguer, J., Rodrı́guez-Martı́nez, D., Mercader, J., & Velicia, R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80216-0 · Cited by 268 · see citing works
Transplantation for Primary Biliary Cirrhosis: Retrospective Analysis of 400 Patients in A Single Center
Garcia, R. F. L., Garcia, C. E., McMaster, P., & Neuberger, J. (2001) · Hepatology · doi:10.1053/jhep.2001.20894 · Cited by 254 · see citing works
Long‐term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
Angulo, P., Batts, K. P., Therneau, T. M., Jorgensen, R. A., Dickson, R. E., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510290301 · Cited by 234 · see citing works
Self-citation
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis
Poupon, R. E., Lindor, K. D., Parés, A. R., Chazouillères, O., Poupon, R. Y., & Heathcote, E. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00192-2 · Cited by 215 · see citing works
Self-citation
Primary biliary cirrhosis
Hübscher, S. G., Elias, E., Buckels, J. A. C., Mayer, A. D., McMaster, P. D., & Neuberger, J. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80244-2 · Cited by 180 · see citing works
Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation
Neuberger, J., Gunson, B., Hubscher, S., & Nightingale, P. (2004) · Liver Transplantation · doi:10.1002/lt.20123 · Cited by 155 · see citing works
Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history
Sylvestre, P. B., Batts, K. P., Burgart, L. J., Poterucha, J. J., & Wiesner, R. H. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50213 · Cited by 148 · see citing works
Self-citation
PREDNISONE WITHDRAWAL 14 DAYS AFTER LIVER TRANSPLANTATION WITH MYCOPHENOLATE
Stegall, M. D., Wachs, M. E., Everson, G. T., Steinberg, T. G., Bilir, B. M., Shrestha, R., Karrer, F. M., & Kam, I. (1997) · Transplantation · doi:10.1097/00007890-199712270-00023 · Cited by 132 · see citing works
Long‐term follow‐up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients
Jacob, D., Neumann, U. P., Bahra, M., Klupp, J., Puhl, G., Neuhaus, R., & Langrehr, J. M. (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2005.00471.x · Cited by 119 · see citing works
The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation
Sanchez, E. Q., Levy, M. F., Goldstein, R. M., Fasola, C. G., Tillery, G. W., Netto, G. J., Watkins, D. L., Weinstein, J. S., Murray, N., Byers, D. E., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000090867.83666.f7 · Cited by 113 · see citing works
Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis
Polson, R. J., Portmann, B., Neuberger, J., Calne, R., & Williams, R. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90643-4 · Cited by 111 · see citing works
Replicative Senescence of Biliary Epithelial Cells Precedes Bile Duct Loss in Chronic Liver Allograft Rejection
Lunz, J. G., Contrucci, S., Ruppert, K. M., Murase, N., Fung, J. J., Starzl, T. E., & Demetris, A. J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64089-8 · Cited by 107 · see citing works
Recurrent Primary Biliary Cirrhosis
Guy, J. E., Qian, P., Lowell, J. A., & Peters, M. G. (2005) · Liver Transplantation · doi:10.1002/lt.20511 · Cited by 87 · see citing works
Disease recurrence after living liver transplantation for primary biliary cirrhosis: A clinical and histological follow-up study
Hashimoto, E., Shimada, M., Noguchi, S., Taniai, M., Tokushige, K., Hayashi, N., Takasaki, K., Fuchinoue, S., & Ludwig, J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25357 · Cited by 67 · see citing works
HISTOLOGICAL FEATURES PREDICTIVE OF RECURRENCE OF PRIMARY BILIARY CIRRHOSIS AFTER LIVER TRANSPLANTATION
Sebagh, M., Farges, O., Dubel, L., Samuel, D., Bismuth, H., & REYNES, M. (1998) · Transplantation · doi:10.1097/00007890-199805270-00008 · Cited by 67 · see citing works
The impact of liver transplantation on endocrine status in men
Stephan Madersbacher, A., Ludvik, G., Stulnig, T. M., Gruenberger, T., & Maier, U. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.698519.x · Cited by 59 · see citing works
The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation
Levitsky, J., Hart, J. A. L., Cohen, S. M., & Te, H. S. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50132 · Cited by 58 · see citing works
Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients
Gómez, R., and, E. M., Colina, F., Loinaz, C., González-Pinto, I., Lumbreras, C., Perez-Cerda, F., Pavón, C. J. C., & García, I. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80214-6 · Cited by 48 · see citing works
Effects of different calcineurin inhibitors on sex hormone levels in transplanted male patients
Kantarcı, G., Şahin, S., Uras, A. R., & Ergin, H. (2004) · Transplantation Proceedings · doi:10.1016/j.transproceed.2003.11.017 · Cited by 47 · see citing works
Does Primary Biliary Cirrhosis in Men Differ from Primary Biliary Cirrhosis in Women?† ‡ §
Rubel, L. R., Rabin, L., Seeff, L. B., Licht, H., & Cuccherini, B. A. (1984) · Hepatology · doi:10.1002/hep.1840040418 · Cited by 41 · see citing works
Transferrin receptor recycling in rat hepatocytes is regulated by protein phosphatase 2A, possibly through effects on microtubule-dependent transport
Runnegar, M. T. C., Wei, X., Berndt, N., & Hamm‐Alvarez, S. F. (1997) · Hepatology · doi:10.1002/hep.510260123 · Cited by 37 · see citing works
Liver Transplantation for Primary Biliary Cirrhosis: Influence of Primary Immunosuppression on Survival
Jacob, D., Neumann, U. P., Bahra, M., Langrehr, J. M., & Neuhaus, P. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.03.130 · Cited by 35 · see citing works
The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients ? a randomised prospective study
Harper, S. J., Moorhouse, J., Abrams, K. R., Jurewicz, A., Nicholson, M. R., Horsburgh, T., Harris, K. M., Combe, C., Bell, P. R. F., Walls, J., et al. (1996) · Transplant International · doi:10.1007/bf00336388 · Cited by 30 · see citing works
Clinical relevance of recurrence of primary biliary cirrhosis after liver transplantation
Haagsma, E. B. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199906000-00009 · Cited by 23 · see citing works
Clinical significance of recurrent primary biliary cirrhosis after liver transplantation
Knoop, M., Bechstein, W., Schrem, H., Lobeck, H., Hopf, U., & Neuhaus, P. (1996) · Transplant International · doi:10.1111/j.1432-2277.1996.tb01586.x · Cited by 19 · see citing works
The impact of advancing donor age on histologic recurrence of hepatitis C infection: The perils of ignored maternal advice
Charlton, M. (2003) · Liver Transplantation · doi:10.1002/lt.500090516 · Cited by 18 · see citing works
Clinical significance of recurrent primary biliary cirrhosis after liver transplantation
Knoop, M., Bechstein, W. O., Schrem, H., Neuhaus, P., Lobeck, H., & Hopf, U. (1996) · Springer eBooks · doi:10.1007/978-3-662-00818-8_30 · Cited by 18 · see citing works
Current concepts in the pathogenesis of primary biliary cirrhosis
Charatcharoenwitthaya, P., & Lindor, K. D. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32061-7 · Cited by 15 · see citing works
Self-citation
Future Treatment Options in PBC
Vierling, J. M. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-916326 · Cited by 14 · see citing works
Recurrence of primary biliary cirrhosis after liver transplantation
Salguero, O. O. D. R., Moreno, J. M., Seijas, M. C., Rubio, E., Salas, C., Laporta, R., & Cuervas‐Mons, V. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00064-2 · Cited by 12 · see citing works
The Canadian Multicenter Double‐blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis
Heathcote, J. E., Cauch-Dudek, K., Walker, V., Bailey, R. J., Blendis, L. M., Ghent, C. N., Michieletti, P., Minuk, G. Y., Pappas, C. S., Scully, L. J., et al. (1994) · Hepatology · doi:10.1002/hep.1840190512 · Cited by 2 · see citing works

Flagged first, then by citations

Research works printed but not linked: 3

Abu-Elamgd K, Demetris J, Rakela J, Balan V, Vinayek R, Irish W, et al. Transplantation for primary biliary cirrho- sis: recurrence and outcome in 421 patients [Abstract]. Hepatology 1997;26:176A.
CHARATCHAROENWITTHAYA ET AL. LIVER TRANSPLANTATION.DOI 10.1002/lt. Published on behalf of the American Association for the Study of Liver Diseases 15276473, 2007, 9, · DOI
Starzl TE, Demetris AJ, Van Thiel D. Liver transplanta- tion. N Engl J Med. 1989;321:1014-1022.

Sorted by citations

Primary biliary cirrhosis # †
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099 · see citing works
Self-citation
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913 · see citing works
Self-citation
Primary biliary cirrhosis
Selmi, C., Bowlus, C. L., Gershwin, M. E., & Coppel, R. L. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61965-4 · Cited by 334 · see citing works
Primary Biliary Cirrhosis
Hirschfield, G. M., & Heathcote, E. J. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch32 · Cited by 260 · see citing works
Primary biliary cholangitis
Lleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253 · see citing works
Autoimmune liver disease, autoimmunity and liver transplantation
Carbone, M., & Neuberger, J. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.020 · Cited by 250 · see citing works
Recent advances in clinical practice: Epidemiology of autoimmune liver diseases
Trivedi, P. J., & Hirschfield, G. M. (2021) · Gut · doi:10.1136/gutjnl-2020-322362 · Cited by 244 · see citing works
The Cholangiopathies
Lazaridis, K. N., & LaRusso, N. F. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.03.017 · Cited by 216 · see citing works
Diagnosis and Management of Primary Biliary Cholangitis
Younossi, Z. M., Bernstein, D., Shiffman, M. L., Kwo, P. Y., Kim, W. R., Kowdley, K. V., & Jacobson, I. M. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0390-3 · Cited by 213 · see citing works
The impact of disease recurrence on graft survival following liver transplantation: a single centre experience
Rowe, I. A. C., Webb, K., Gunson, B. K., Mehta, N. N., Haque, S. M., & Neuberger, J. (2008) · Transplant International · doi:10.1111/j.1432-2277.2007.00628.x · Cited by 196 · see citing works
Current understanding of primary biliary cholangitis
Tanaka, A. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0028 · Cited by 159 · see citing works
Differences in long‐term survival among liver transplant recipients and the general population: A population‐based nordic study
Åberg, F. O., Gissler, M., Karlsen, T. H., Ericzon, B., Foss, A. E., Rasmussen, A., Bennet, W., Olausson, M., Line, P., Nordin, A. J., et al. (2014) · Hepatology · doi:10.1002/hep.27538 · Cited by 148 · see citing works
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival
Montaño‐Loza, A. J., Hansen, B. E., Corpechot, C., Roccarina, D., Thorburn, D., Trivedi, P. J., Hirschfield, G. M., McDowell, P., Poupon, R. Y., Dumortier, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.001 · Cited by 129 · see citing works
Systematic review: recurrent autoimmune liver diseases after liver transplantation
Montaño‐Loza, A. J., Bhanji, R. A., Wasilenko, S. T., & Mason, A. L. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13894 · Cited by 124 · see citing works
Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy
Purohit, T. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i7.926 · Cited by 118 · see citing works
Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence
Bosch, A., Dumortier, J., Maucort-Boulch, D., Scoazec, J.-Y., Wendum, D., Conti, F., Morard, I., Rubbia-Brandt, L., Terris, B., Radenne, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.038 · Cited by 114 · see citing works
Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
Kotb, M. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078882 · Cited by 114 · see citing works
Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation
Duclos‐Vallée, J., & Sebagh, M. (2009) · Liver Transplantation · doi:10.1002/lt.21916 · Cited by 112 · see citing works
Guidelines for the management of primary biliary cirrhosis
Cirrhosis, W. S. (. V. F. C. P. G. F. P. B. (2014) · Hepatology Research · doi:10.1111/hepr.12270 · Cited by 111 · see citing works
Liver transplantation and autoimmune liver diseases
Liberal, R., Zen, Y., Mieli‐Vergani, G., & Vergani, D. (2013) · Liver Transplantation · doi:10.1002/lt.23704 · Cited by 103 · see citing works
Cyclosporine A Protects Against Primary Biliary Cirrhosis Recurrence After Liver Transplantation
Montano, A. J., Wasilenko, S., Bintner, J., & Mason, A. L. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.03006.x · Cited by 99 · see citing works
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis
Corpechot, C., Chazouillères, O., Belnou, P., Montaño‐Loza, A. J., Mason, A. L., Ebadi, M., Eurich, D., Chopra, S., Jacob, D., Schramm, C., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.043 · Cited by 91 · see citing works
Liver transplantation in PBC and PSC: Indications and disease recurrence
Carbone, M., & Neuberger, J. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.02.007 · Cited by 89 · see citing works
Living Donor and Deceased Donor Liver Transplantation for Autoimmune and Cholestatic Liver Diseases—An Analysis of the UNOS Database
Kashyap, R., Safadjou, S., Chen, R., Mantry, P., Sharma, R. K., Patil, V. P., Maloo, M. K., Ryan, C., Marroquin, C. E., Barry, C. T., et al. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1256-1 · Cited by 89 · see citing works
Recurrent primary biliary cirrhosis after liver transplantation
Silveira, M. G., Talwalkar, J. A., Lindor, K. D., & Wiesner, R. H. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03038.x · Cited by 86 · see citing works
Self-citation
Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis
Karlsen, T. H., Vesterhus, M. N., & Boberg, K. M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12581 · Cited by 86 · see citing works
One‐Pot Multienzymatic Synthesis of 12‐Ketoursodeoxycholic Acid: Subtle Cofactor Specificities Rule the Reaction Equilibria of Five Biocatalysts Working in a Row
Monti, D., Ferrandi, E. E., Zanellato, I., Hua, L., Polentini, F., Carrea, G., & Riva, S. (2009) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.200800727 · Cited by 83 · see citing works
S2k Leitlinie Autoimmune Lebererkrankungen
Authors, Collaborators:, durch:, E. B., Deutsche Gesellschaft für Gastroenterologie, V. U. S. (. (., (DGIM), D. G. F. I. M., (DCCV), D. M. C. U. V., e.V., D. L., (DEGUM), D. G. F. U. I. D. M., (DGE-BV), D. G. F. E. U. B. V., (DGKJ), D. G. F. K. U. J., et al. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0043-120199 · Cited by 85 · see citing works
Liver transplantation in autoimmune liver diseases
Ilyas, J. A., O'Mahony, C. A., & Vierling, J. M. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.09.008 · Cited by 80 · see citing works
Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?
Schreuder, T. C. M. A., Hübscher, S. G., & Neuberger, J. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00729.x · Cited by 71 · see citing works
Primary biliary cirrhosis after liver transplantation: Influence of immunosuppression and human leukocyte antigen locus disparity
Manousou, P., Arvaniti, V., Tsochatzis, E. A., Isgrò, G., Jones, K., Shirling, G., Dhillon, A. P., O’Beirne, J. P., Patch, D., & Burroughs, A. K. (2009) · Liver Transplantation · doi:10.1002/lt.21960 · Cited by 70 · see citing works
Transplantation in autoimmune liver diseases.
Mottershead, M., & Neuberger, J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3388 · Cited by 58 · see citing works
Long-Term Outcomes of Living-Donor Liver Transplantation for Primary Biliary Cirrhosis: A Japanese Multicenter Study
Egawa, H., Sakisaka, S., Teramukai, S., Sakabayashi, S., Yamamoto, M., Umeshita, K., & Üemoto, S. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13583 · Cited by 55 · see citing works
Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation
Visseren, T., & Murad, S. D. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.04.004 · Cited by 53 · see citing works
Gut–liver axis: an immune link between celiac disease and primary biliary cirrhosis
Volta, U., Caio, G., Tovoli, F., & GIORGIO, R. D. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.13.5 · Cited by 51 · see citing works
Liver Transplantation for Cholestatic Liver Diseases in Adults
Khungar, V., & Goldberg, D. S. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.011 · Cited by 52 · see citing works
Obeticholic acid for the treatment of primary biliary cholangitis
Ali, A. H., & Lindor, K. D. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1218471 · Cited by 50 · see citing works
Self-citation
The Unfinished Business of Primary Biliary Cirrhosis
Selmi, C., Zuin, M., & Gershwin, M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.006 · Cited by 44 · see citing works
Liver transplantation for overlap syndromes of autoimmune liver diseases
Bhanji, R. A., Mason, A. L., Girgis, S., & Montaño‐Loza, A. J. (2012) · Liver International · doi:10.1111/liv.12027 · Cited by 49 · see citing works
Recurrent and De Novo Autoimmune Liver Diseases
Mendes, F. D., Couto, C. A., & Levy, C. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.08.008 · Cited by 49 · see citing works
Incidence and risk factors associated withde novoautoimmune hepatitis after liver transplantation
Montaño‐Loza, A. J., Vargas-Vorácková, F., Ma, M. M., Bain, V. G., Burak, K. W., Kumar, T., & Mason, A. L. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02832.x · Cited by 47 · see citing works
Autoimmune Liver Disease Post-Liver Transplantation
Edmunds, C., & Ekong, U. D. (2015) · Transplantation · doi:10.1097/tp.0000000000000922 · Cited by 43 · see citing works
Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation
Šembera, Š., Lammert, C. S., Talwalkar, J. A., Sanderson, S. O., Poterucha, J. J., Hay, J. E., Wiesner, R. H., Gores, G. J., Rosen, C. B. B., Heimbach, J. K., et al. (2012) · Liver Transplantation · doi:10.1002/lt.23424 · Cited by 41 · see citing works
Self-citation
Recurrence of autoimmune liver diseases after liver transplantation
Faisal, N. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i29.2896 · Cited by 37 · see citing works
Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation: A Meta‐Analysis
Pedersen, M. R., Greenan, G., Arora, S. S., Murali, A. R., & Mayo, M. J. (2020) · Liver Transplantation · doi:10.1002/lt.25935 · Cited by 35 · see citing works
Recurrence of non-viral liver disease after orthotopic liver transplantation
El‐Masry, M., Gilbert, C. P., & Saab, S. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02434.x · Cited by 31 · see citing works
Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study
Kogiso, T., Egawa, H., Teramukai, S., Taniai, M., Hashimoto, E., Tokushige, K., Sakisaka, S., Sakabayashi, S., Yamamoto, M., Umeshita, K., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1037 · Cited by 31 · see citing works
Liver transplantation in primary biliary cirrhosis.
Milkiewicz, P. (2008) · Clinical Liver Disease · doi:10.1016/j.cld.2008.02.015 · Cited by 14 · see citing works
S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)
Berg, T., Aehling, N., Bruns, T., Welker, M., Weismüller, T. J., Trebicka, J., Tacke, F., Strnad, P., Sterneck, M. R., Settmacher, U., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2255-7246 · Cited by 29 · see citing works
PBC-transplantation and disease recurrence
Nevens, F. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.09.001 · Cited by 27 · see citing works
Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis
Montaño‐Loza, A. J., Wasilenko, S. T., Bintner, J., & Mason, A. L. (2009) · Liver International · doi:10.1111/j.1478-3231.2010.02257.x · Cited by 26 · see citing works
Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study
Hytiroglou, P., Gutierrez, J. A., Freni, M., Odin, J. A., Stanca, C. M., Merati, S., Schiano, T. D., Branch, A. D., & Thung, S. N. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00483.x · Cited by 26 · see citing works
Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: an Update on MR Imaging Findings with Recent Developments
Kovač, J. D., & Weber, M. D. (2016) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.254.vac · Cited by 26 · see citing works
Current Status of Liver Transplantation for Primary Biliary Cholangitis.
Aguilar, M. T., & Carey, E. J. (2018) · Clinical Liver Disease · doi:10.1016/j.cld.2018.03.011 · Cited by 23 · see citing works
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement
Montaño‐Loza, A. J., Corpechot, C., Burra, P., Schramm, C., Selzner, N., Ronca, V., & Oo, Y. H. (2024) · Liver Transplantation · doi:10.1097/lvt.0000000000000419 · Cited by 25 · see citing works
Liver Transplant for Cholestatic Liver Diseases
Carrion, A. F., & Bhamidimarri, K. R. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.12.005 · Cited by 25 · see citing works
Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid
Satapathy, S. K., Jones, O. D., Vanatta, J. M., Kamal, F., Kedia, S., Jiang, Y., Nair, S. P., & Eason, J. D. (2017) · Transplantation Direct · doi:10.1097/txd.0000000000000693 · Cited by 24 · see citing works
Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus
Tanaka, A., Kono, H., Leung, P. S. C., & Gershwin, M. E. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.104021 · Cited by 22 · see citing works
Risk factors for recurrent primary biliary cirrhosis after liver transplantation: A systematic review and meta-analysis
Li, X., Peng, J., Ouyang, R., Yang, Y., Yu, C., & Lin, H. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.12.005 · Cited by 22 · see citing works
Liver Transplantation for Primary Biliary Cholangitis
Martin, E. F. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.014 · Cited by 22 · see citing works
Diagnosis and management of primary biliary cirrhosis
Ali, A. H., Carey, E. J., & Lindor, K. D. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.979792 · Cited by 22 · see citing works
Self-citation
The immunoreactive patient: Rejection and autoimmune disease
O’Grady, J. (2011) · Liver Transplantation · doi:10.1002/lt.22413 · Cited by 21 · see citing works
Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients
Peng, S. S., Jeng, Y., Hsu, W., Yang, C.-T., & Ho, M. (2015) · European Radiology · doi:10.1007/s00330-015-3716-1 · Cited by 20 · see citing works
Hepatobiliar manifestations in inflammatory bowel disease: A practical approach
Paulina Núñez, F., Castro, F., Gabriel Mezzano, P., Quera, R., Díaz, D., & Castro, L. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i2.319 · Cited by 23 · see citing works
Why Doesn’t Primary Biliary Cholangitis Respond to Immunosuppressive Medications?
Molinaro, A., & Marschall, H. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0345-y · Cited by 19 · see citing works
Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects
Cholongitas, Ε., & Burroughs, A. K. (2012) · Autoimmunity Highlights · doi:10.1007/s13317-012-0040-5 · Cited by 18 · see citing works
Cholestatic Liver Diseases After Liver Transplant
Polanco, N. A. P., Levy, C., & Martin, E. F. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.12.011 · Cited by 18 · see citing works
Role of Novel Retroviruses in Chronic Liver Disease: Assessing the Link of Human Betaretrovirus with Primary Biliary Cirrhosis
Sharon, D. M., & Mason, A. L. (2015) · Current Infectious Disease Reports · doi:10.1007/s11908-014-0460-7 · Cited by 17 · see citing works
Post-Transplant Immunosuppression in Autoimmune Liver Disease
Kelly, C., Zen, Y., & Heneghan, M. A. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.07.002 · Cited by 17 · see citing works
Emerging drugs for the treatment of Primary Biliary Cholangitis
Ali, A. H., Tabibian, J. H., Carey, E. J., & Lindor, K. D. (2016) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2016.1150999 · Cited by 17 · see citing works
Self-citation
Primary Biliary Cirrhosis
Angulo, P., & Lindor, K. D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00089-5 · Cited by 17 · see citing works
Self-citation
Long-term outcome of living donor liver transplantation for primary biliary cirrhosis
Kaneko, J., Sugawara, Y., Tamura, S., Aoki, T., Hasegawa, K., Yamashiki, N., & Kokudo, N. (2011) · Transplant International · doi:10.1111/j.1432-2277.2011.01336.x · Cited by 16 · see citing works
Other Potential Medical Therapies: The Use of Antiviral Agents to Investigate and Treat Primary Ciliary Cirrhosis
Mason, A. L., & Wasilenko, S. T. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.006 · Cited by 16 · see citing works
Liver Transplantation for Primary Biliary Cirrhosis: Results of Aggressive Corticosteroid Withdrawal
Campsen, J., Zimmerman, M. A., Trotter, J. F., Wachs, M. E., Bak, T., Steinberg, T. G., Kaplan, M. M., & Kam, I. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.10.095 · Cited by 15 · see citing works
Outcome of Liver Transplantation for Recipients With Hepatitis B and Hepatitis C Virus Coinfection: Analysis of the UNOS Data
Waki, K., Sugawara, Y., Tamura, S., Mieno, M., Yamashiki, N., Kadowaki, T., & Kokudo, N. (2011) · Transplantation · doi:10.1097/tp.0b013e31822d4dc3 · Cited by 15 · see citing works
Transplantation Pathology
Clouston, A. D., & Hübscher, S. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00014-5 · Cited by 15 · see citing works
Primary biliary cirrhosis and liver transplantation
Akamatsu (2012) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2012.v1.2.66 · Cited by 15 · see citing works
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis
Carbone, M., Gerussi, A., Cardinale, V., Cazzagon, N., Cossiga, V., Lleò, A., Marrone, G., Marzioni, M., Moschetta, A., Muratori, L., et al. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.05.002 · Cited by 16 · see citing works
Recurrence of Nonviral Liver Diseases After Liver Transplantation
Graziadei, I. W. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2014.05.009 · Cited by 14 · see citing works
Epidemiology and liver transplantation burden of primary biliary cholangitis: a retrospective cohort study
Yoshida, E. M., Mason, A. L., Peltekian, K. M., Shah, H., Thiele, S. L., Borrelli, R., & Fischer, A. (2018) · CMAJ Open · doi:10.9778/cmajo.20180029 · Cited by 15 · see citing works
Liver transplantation in chronic cholestatic conditions.
Milkiewicz, P., Wunsch, E., & Elias, E. (2012) · Frontiers in Bioscience · doi:10.2741/3966 · Cited by 13 · see citing works
De Novo Autoimmune Hepatitis With Centrilobular Necrosis Following Liver Transplantation for Primary Biliary Cirrhosis: A Case Report
Zhang, Y., Wang, B., & Wang, T. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.08.062 · Cited by 13 · see citing works
An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know
Toniutto, P., Germani, G., Ferrarese, A., Bitetto, D., Zanetto, A., Fornasiere, E., Fumolo, E., Shalaby, S., & Burra, P. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.08.005 · Cited by 12 · see citing works
Antibody-Mediated Rejection and Recurrent Primary Disease: Two Main Obstacles in Abdominal Kidney, Liver, and Pancreas Transplants
Nakamura, T., & Shirouzu, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225417 · Cited by 12 · see citing works
Transplantation Pathology of the Liver
Demetris, A. J., Crawford, J. M., Minervini, M. I., Nalesnik, M., Ochoa, E. R., Randhawa, P. S., Sasatomi, E., & Wu, T. (2009) · Elsevier eBooks · doi:10.1016/b978-141604059-0.50047-3 · Cited by 12 · see citing works
Evaluation of an Abnormal Liver Panel After Liver Transplantation
Henson, J. B., & Muir, A. J. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.08.006 · Cited by 11 · see citing works
Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence
Henson, J. B., & King, L. Y. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.07.009 · Cited by 11 · see citing works
Follow-up of the Post-Liver Transplantation Patient
Cheung, A. C., & Levitsky, J. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.06.006 · Cited by 11 · see citing works
Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?
Smyk, D. S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i35.4855 · Cited by 10 · see citing works
Update on Emerging Treatment Options for Primary Biliary Cholangitis
Aguilar, M. T., & Chascsa, D. M. H. (2020) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s205431 · Cited by 10 · see citing works
Large-scale Enzymatic Synthesis of 12-Ketoursodeoxycholic Acid from Dehydrocholic Acid by Simultaneous Combination of 3α-Hydroxysteroid Dehydrogenase from Pseudomonas testosteroni and 7β-Hydroxysteroid Dehydrogenase from Collinsella aerofaciens
Bakonyi, D., Wirtz, A., & Hummel, W. (2012) · Zeitschrift für Naturforschung B · doi:10.5560/znb.2012-0165 · Cited by 10 · see citing works
How, why, and when does primary biliary cirrhosis recur after liver transplantation?
Williams, R. L., & Gershwin, M. E. (2007) · Liver Transplantation · doi:10.1002/lt.21143 · Cited by 10 · see citing works
Switching From Tacrolimus to Cyclosporine A to Prevent Primary Biliary Cirrhosis Recurrence After Living-Donor Liver Transplantation
Shiba, H., Wakiyama, S., Futagawa, Y., Gocho, T., Ito, R., Furukawa, K., Ishida, Y. Y., Misawa, T., & Yanaga, K. K. (2013) · International Surgery · doi:10.9738/cc188 · Cited by 9 · see citing works
Primary Biliary Cholangitis Guidance Update: Implications for Liver Transplantation
Levy, C. (2018) · Liver transplantation · doi:10.1002/lt.25321 · Cited by 10 · see citing works
Management of Autoimmune Liver Diseases after Liver Transplantation
Barba, R., Medina‐Morales, E., Goyes, D., Patwardhan, V. R., & Bonder, A. (2021) · Transplantology · doi:10.3390/transplantology2020016 · Cited by 9 · see citing works
Disease recurrence plays a minor role as a cause for retransplantation after living‐donor liver transplantation for primary biliary cirrhosis: A multicenter study in J apan
Egawa, H., Nakanuma, Y., Maehara, Y., Üemoto, S., Eguchi, S., Sato, Y., Shirabe, K., Takatsuki, M., Mori, A. S., Yamamoto, M., et al. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01108.x · Cited by 9 · see citing works
Recipient-Based Approach to Tailoring Immunosuppression in Liver Transplantation
Kemmer, N. M., & Neff, G. W. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.02.076 · Cited by 9 · see citing works
Recurrent nonviral liver disease following liver transplantation
Li, K., & Neuberger, J. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.16 · Cited by 8 · see citing works
Primary Biliary Cirrhosis
Silveira, M. G. (2014) · Clinical gastroenterology · doi:10.1007/978-1-4939-1013-7_3 · Cited by 9 · see citing works
Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients
Mijić, M., Saric, I., Delija, B., Lalovac, M., Sobočan, N., Radetić, E., Martinčević, D., & Kanižaj, T. F. (2022) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2022/7831165 · Cited by 8 · see citing works

Preventive Administration of Ursodeoxycholic Acid after Liver Transplantation for Primary Biliary Cholangitis Prevents Disease Recurrence and Prolongs Graft Survival
Corpechot, C., Chazouillères, O., Belnou, P., Montaño‐Loza, A. J., Mason, A. L., Ebadi, M., Eurich, D., Chopra, S., Jacob, D. G., Schramm, C., et al. (2019) · HAL · Cited by 2 · see citing works
Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence
Bosch, A., Dumortier, J., Maucort-Boulch, D., Scoazec, J.-Y., Wendum, D., Conti, F., Morard, I., Rubbia-Brandt, L., Terris, B., Radenne, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.038 · Cited by 114 · see citing works
Recurrence of Primary Biliary Cirrhosis Following Liver Transplantation
Wiesner, R. H. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2947-4_5
Self-citation
Recurrent Primary Biliary Cirrhosis
Guy, J. E., Qian, P., Lowell, J. A., & Peters, M. G. (2005) · Liver Transplantation · doi:10.1002/lt.20511 · Cited by 87 · see citing works
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.001 · Cited by 289 · see citing works
Self-citation

Authors: Charatcharoenwitthaya, P., Pimentel, S., Talwalkar, J. A., Enders, F. T., Lindor, K. D., Krom, R. A. F., & Wiesner, R. H.
Affiliations: Mayo Clinic (US)
Corresponding author: Talwalkar, Jayant A.
ORCID: Charatcharoenwitthaya, Phunchai
Enders, Felicity T.
Lindor, Keith D.
Venue: Liver Transplantation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2007
Volume: 13
Issue: 9
Pages: 1236-1245
ISSN: 1527-6465 (ISSN-L)
1527-6473
DOI: 10.1002/lt.21124
OpenAlex: W2022135364
Cited by: 179
References: 45
Citations by year: 2026: 2 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 8 · 2021: 9 · 2020: 19 · 2019: 3 · 2018: 13 · 2017: 12 · 2016: 7 · 2015: 14 · 2014: 10 · 2013: 11 · 2012: 13
FWCI: 6.35
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 3165 d)
Locations: Liver Transplantation (publishedVersion)
PubMed (publishedVersion)
Funders: Mahidol University
Faculty of Medicine Siriraj Hospital, Mahidol University
Topics: Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords: primary biliary cirrhosis, ursodeoxycholic acid, patient survival, graft survival, liver retransplantation, biochemical markers, histological progression, long-term follow-up
MeSH terms: Adult, Aged, Cholagogues and Choleretics, Female, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Probability, Recurrence, Retrospective Studies, Ursodeoxycholic Acid, Survival Analysis, Liver Transplantation, Survivors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Long‐term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation

Abstract

Integrity signals

Claims the paper makes

Self-check

Cites

Cited by

Related

Record

About these checks